On 2024-03-11, Legend Biotech Corporation Sponsored ADR (LEGN) announced earnings per share of $-0.40 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.70.
The next expected annoucement date for quarterly earnings is 2024-05-13, with an average estimated earnings per share of $-0.24 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-11 | 2023-12-31 | $-0.70 | $-0.40 |
| 2023-11-20 | 2023-09-30 | $-0.56 | $-0.17 |
| 2023-08-15 | 2023-06-30 | $-0.69 | $-0.27 |
| 2023-05-18 | 2023-03-31 | $-0.56 | $-0.40 |
| 2023-02-17 | 2022-06-30 | -- | $-0.41 |
| 2022-06-01 | 2022-03-31 | $-0.37 | $-0.24 |
| 2022-03-18 | 2021-12-31 | $-0.35 | $-0.38 |
| 2021-11-16 | 2021-09-30 | $-0.35 | $-0.43 |
| 2021-08-23 | 2021-06-30 | $-0.31 | $-0.32 |
| 2021-05-18 | 2021-03-31 | $-0.38 | $-0.30 |
| 2021-03-18 | 2020-12-31 | $-0.28 | $-0.22 |
| 2020-11-16 | 2020-09-30 | $-0.31 | $-0.25 |
| 2020-08-28 | 2020-06-30 | $-0.26 | $-0.26 |